Table 3.
All-cause mortality | CVD mortality | Cancer mortality | |||||||
---|---|---|---|---|---|---|---|---|---|
Cases/PY | incidence per 10000 PY | HR (95% CI) | Cases/PY | Incidence per 10000 PY | HR (95% CI) | Cases/PY | Incidence per 10000 PY | HR (95% CI) | |
LTPA | 332/23,530 | 141 | 0.82 (0.73 to 0.91) | 106/23,373 | 45 | 0.83 (0.67 to 1.00) | 84/23,373 | 36 | 1.02 (0.82 to 1.28) |
SPA | 321/23,365 | 137 | 0.80 (0.71 to 0.91) | 106/23,365 | 45 | 0.80 (0.64 to 1.00) | 84/23,365 | 36 | 0.80 (0.63 to 1.03) |
WPA | 34/11,740 | 29 | 1.03 (0.71 to 1.49) | 6/11,740 | 5 | 1.29 (0.51 to 3.28) | 13/11,741 | 11 | 0.82 (0.47 to 1.46) |
(SD, standard deviation. HR, hazards ratio. CI, confidence interval. PY = person years. All models included age, sex, years of schooling, income, smoking, body mass index in addition to the exposure variables. One Cox regression for a one SD increase in LTPA, SPA and WPA was run for each exposure-outcome combination).